| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $248K | +0.0% |
| R&D Expense | $9.8M | +88.7% |
| SG&A Expense | $14.3M | +242.2% |
| Operating Income | -$25.2M | -143.4% |
| Pre-tax Income | -$28.0M | -144.2% |
| Income Tax | $18K | -14.4% |
| Net Income | -$28.0M | -143.9% |
| EPS (Basic) | -$0.39 | -105.3% |
| EPS (Diluted) | -$0.39 | -105.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $97.2M | — |
| Short-term Investments | $200.6M | — |
| Current Assets | $299.6M | — |
| Total Assets | $303.0M | +28.3% |
| Current Liabilities | $5.9M | +1190.3% |
| Total Liabilities | $7.6M | -32.2% |
| Stockholders' Equity | $295.4M | +2966.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.5M | -100.8% |
| Capital Expenditures | $1.1M | +73.6% |
| Investing Cash Flow | -$200.6M | — |
| Financing Cash Flow | $311.4M | +4192.6% |
| Free Cash Flow | -$17.5M | -98.9% |